Warren RB, de Bruin-Weller M, Tsianakas A, Khemis A, et al. Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage). Br J Dermatol 2025 Sep 22:ljaf285. doi: 10.1093.
PMID: 40985295